CarePartners for depression
BehavioralAutomated telephone calls for depression monitoring and self-management support.
NCT Number: NCT01834534
The objective of this research is to test the efficacy of "CarePartners for Depression" (CP-D) intervention, which was designed to increase between visit monitoring of depression status and enhance self-management.
**In order to participate, subjects must be patients at participating clinics: Alcona Health Center, Cherry Street Health Services, Dua Family Practice, Morang Chester.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Alcona Health Centers, Alpena, Michigan, United States
This project will test a practical intervention that uses low cost technologies to activate depressed patients' existing social networks for self-management support. The intervention links patients with a "CarePartner" (CP), i.e., a non-household family member or close friend who is willing to support the patient in coordination with the clinician and any existing in-home caregiver (ICG). Through weekly automated telemonitoring, patients report their mood and self-management status, and receive tailored guidance on self-management. The CP receives a corresponding update along with guidance on how to best support the patient's self-management efforts, and the primary care team is notified about clinically urgent situations. The intervention will be tested among depressed primary care patients from clinics serving low-income and underinsured patients, whom the intervention was especially designed to benefit. Specific Aim 1 is to conduct a randomized controlled trial to compare the effectiveness of one year of telemonitoring-supported CP for depression versus usual care (control) on depression severity. Specific Aim 2 is to examine key secondary outcomes (response and remission, impairment, well-being, caregiving burden, healthcare costs) and potential moderators. Specific Aim 3 is to use a mixed-methods approach to enrich our interpretation of the statistical associations, and to discover strategies to enhance the intervention's acceptability, effectiveness, and sustainability. If the intervention proves effective without increasing clinician burden or marginal costs, then its subsequent implementation could yield major public health benefits, especially in medically underserved populations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
NOTE: In order to participate, must have received medical care for past year at one of the participating clinics: Alcona Health Center, Cherry Street Health Services, Dua Family Practice, Morang Chester
Additional Inclusion Criteria:
Exclusion criteria
Automated telephone calls for depression monitoring and self-management support.
Time frame: 12 months after randomization
Patient Health Questionnaire 9 (PHQ-9).
Time frame: 12 months after randomization
Remission as measured by PHQ-9 <10
Time frame: 12 months after randomization
Sheehan Disability Scale
Time frame: 12 months after randomization
Positive well-being will be assessed using the REMIT, a 5-item scale of positive affect and other aspects of depression recovery developed by the PI and his colleagues. Reference: Nease DE, Jr., Aikens, JE, Klinkman, MK, Kroenke, K, and Sen, A. Toward a more comprehensive assessment of depression remission: the Remission Evaluation and Mood Inventory Tool (REMIT). Journal of General Hospital Psychiatry. 2011.
Time frame: 12 months after randomization
Health care costs will be estimated using data gathered from a variety of patient self-report and site-specific administrative databases.
University of Michigan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05321628
Anxiety Disorders, Behavior
Stockholm, Huddinge, Sweden
View Trial DetailsNCT06993662
Anxiety, Anxiety Disorders
Athens, Greece
View Trial DetailsNCT03851380
Behavior, Behavioral Symptoms
Palo Alto, California, United States
View Trial DetailsNCT07741422
Anxiety, Anxiety Disorders
Guangzhou, Guangdong, China
View Trial Details